US2019336553A1PendingUtilityA1
Agent for reducing the number of intestinal bacteria, food, and pharmaceutical product
Est. expiryJan 26, 2036(~9.5 yrs left)· nominal 20-yr term from priority
A61P 37/08A61P 29/00A61P 31/04A61P 1/00A61P 1/14A61P 1/04A61K 2236/51A61K 36/185A61K 36/37A61K 2236/15A61K 2236/331A23V 2002/00
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides an agent for suppressing the number of intestinal bacteria, which contains an extract and/or crushed product of a plant of the genus Salacia, wherein the intestinal bacterium is at least one which is selected from the group consisting of the families Lachnospiraceae, Ruminococcaceae, Fusobacteriaceae, and Desulfovibrionaceae.
Claims
exact text as granted — not AI-modified1 . An agent for suppressing the number of intestinal bacteria, which contains an extract and/or crushed product of a plant of the genus Salacia , wherein the intestinal bacterium is at least one which is selected from the group consisting of the families Lachnospiraceae, Ruminococcaceae, Fusobacteriaceae, and Desulfovibrionaceae.
2 . The agent for suppressing the number of intestinal bacteria according to claim 1 , wherein the intestinal bacterium is at least one which is selected from the group consisting of the family Lachnospiracea, the family Ruminococcaceae, the genus Fusobacterium of the family Fusobacteriaceae, and the genus Desulfovibrio of the family Desulfovibrionaceae.
3 . The agent for suppressing the number of intestinal bacteria according to claim 1 , wherein the intake or dose of the extract and/or crushed product plant of a genus Salacia is not less than 0.5 mg/kg/day.
4 . The agent for suppressing the number of intestinal bacteria according to claim 1 , which is used for prevention or treatment of a gastrointestinal symptom.
5 . The agent for suppressing the number of intestinal bacteria according to claim 4 , wherein the gastrointestinal symptom is a symptom of at least one disease selected from the group consisting of functional dyspepsia, irritable bowel syndrome, inflammatory bowel diseases, Crohn's disease, and ulcerative colitis.
6 . A food for suppressing the number of intestinal bacteria which is selected from the group consisting of the families Lachnospiraceae, Ruminococcacea, Fusobacteriaceae, and Desulfovibrionaceae, which contains the agent for suppressing the number of intestinal bacteria according to claim 1 .
7 . A pharmaceutical product for suppressing the number of intestinal bacteria which is selected from the group consisting of the families Lachnospiraceae, Ruminococcacea, Fusobacteriaceae, and Desulfovibrionaceae, which contains the agent for suppressing the number of intestinal bacteria according to claim 1 .Join the waitlist — get patent alerts
Track US2019336553A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.